Citius Pharmaceuticals, Inc. (CTXR)

NASDAQ: CTXR · Real-Time Price · USD

0.5746

-0.0343 (-5.63%)

At close: Jul 2, 2026, 4:00 PM EDT

0.5850

+0.0104 (1.81%)

After-hours: Jul 2, 2026, 7:56 PM EDT

Citius Pharmaceuticals Balance Sheet

Financials in millions USD. Fiscal year is October - September.

Millions USD. Fiscal year is Oct - Sep.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Sep '25 Sep 30, 2025	Sep '24 Sep 30, 2024	Sep '23 Sep 30, 2023	Sep '22 Sep 30, 2022	Sep '21 Sep 30, 2021
Cash & Equivalents	-	-	-	26.48	41.71	70.07
Cash & Short-Term Investments	-	-	-	26.48	41.71	70.07
Cash Growth	-	-	-	-36.51%	-40.47%	405.59%
Accounts Receivable	1.08	-	-	-	-	-
Inventory	22.66	22.29	8.27	-	-	-
Other Current Assets	3.36	1.4	2.7	7.89	2.85	2.74
Total Current Assets	27.1	23.68	10.97	34.37	44.56	72.81
Net Property, Plant & Equipment	0.79	0.82	0.25	0.46	0.65	0.83
Other Intangible Assets	90.51	92.8	92.8	59.4	59.4	59.4
Goodwill	9.35	9.35	9.35	9.35	9.35	9.35
Other Long-Term Assets	0.21	0.04	0.04	0.04	0.04	0.04
Total Assets	132.54	130.94	116.65	103.61	114	142.43
Accounts Payable	9.45	13.69	4.93	2.93	1.17	1.28
Accrued Expenses	27.74	7.48	2.25	2.63	3.17	2.53
Short-Term Debt	-	1	-	-	-	-
Current Portion of Leases	0.17	0.09	0.24	0.22	0.2	0.18
Other Current Liabilities	17.65	22.65	28.4	-	-	-
Total Current Liabilities	55.02	44.91	35.81	5.78	4.53	3.98
Long-Term Leases	0.64	0.72	0.02	0.26	0.48	0.68
Other Long-Term Liabilities	7.8	7.77	6.71	6.14	5.56	4.99
Total Long-Term Liabilities	8.44	8.5	6.74	6.4	6.04	5.66
Total Liabilities	63.46	53.41	42.55	12.18	10.57	9.65
Common Stock	0.02	0.02	0.01	0.01	0.15	0.15
Additional Paid-in Capital	329.78	306.34	271.44	253.06	232.37	228.08
Retained Earnings	-268.26	-238.8	-201.37	-162.23	-129.69	-96.05
Total Common Shareholders' Equity	61.54	67.55	70.08	90.83	102.83	132.18
Minority Interest	7.54	9.98	4.02	0.6	0.6	0.6
Shareholders' Equity	69.08	77.53	74.1	91.43	103.43	132.78
Total Liabilities & Equity	132.54	130.94	116.65	103.61	114	142.43
Total Debt	0.81	1.81	0.26	0.48	0.68	0.86
Net Cash (Debt)	-0.81	-1.81	-0.26	26	41.03	69.22
Net Cash Growth	-	-	-	-36.64%	-40.72%	453.40%
Net Cash Per Share	-0.04	-0.16	-0.04	4.30	7.02	15.93
Book Value	61.54	67.55	70.08	90.83	102.83	132.18
Book Value Per Share	3.42	6.10	10.42	15.01	17.60	30.43
Tangible Book Value	-38.31	-34.6	-32.07	22.08	34.08	63.44
Tangible Book Value Per Share	-2.13	-3.13	-4.77	3.65	5.83	14.60

SEC Filings: 10-K · 10-Q